Bloomberg News

Novartis Lowers Price for Lucentis Drug By 30 Percent, AWP Says

October 05, 2011

Oct. 5 (Bloomberg) -- Novartis AG will lower the price of its Lucentis drug by 30 percent following pressure from Swiss authorities, Swiss news agency AWP said, citing Le Matin newspaper.

The reduction will also affect prices outside Switzerland as they are derived from prices in the country, AWP said, citing Novartis’s press office.

To contact the reporter on this story: Corinne Gretler in Zurich at cgretler1@bloomberg.net

To contact the editor responsible for this story: Leigh Baldwin at lbaldwin3@bloomberg.net


American Apparel's Future
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus